Online Office
Download CenterMore...
LinksMore...
WeChat
WeChat Code
Website Code
Subscribe Code

Most Downloaded

Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

All
Please wait a minute...
For Selected: Toggle Thumbnails
Guidelines on the management of ascites and complications in cirrhosis Chinese Society of Hepatology, Chinese Medical Association
JOURNAL OF PRACTICAL HEPATOLOGY    2018, 21 (1): 21-31.   DOI: 10.3969/j.issn.1672-5069.2018.01.006
Abstract426)      PDF(pc) (1836KB)(5168)      
Related Articles | Metrics
Guidelines of prevention and treatment for nonalcoholic fatty liver disease:a 2018 update
National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association
JOURNAL OF PRACTICAL HEPATOLOGY    2018, 21 (2): 177-186.   DOI: 10.3969/j.issn.1672-5069.2018.02.007
Abstract815)      PDF(pc) (841KB)(3925)      
Reference | Related Articles | Metrics
Advancement of diagnosis and treatment for caudate hepatocellular carcinoma
Su Beibei,Li Chen,Sang Zejie.
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (6): 762-765.   DOI: 10.3969/j.issn.1672-5069.2016.06.038
Abstract429)      PDF(pc) (738KB)(2737)      
Caudate hepatocellular carcinoma is a special type of malignant tumor located in the caudate lobe of the liver. Surgical resection is difficult to perform because of specific anatomic structure with complex vascular and biliary duct adjacent to the tumor. At present,surgical treatment,interventional therapy,local ablation and radiologic treatment are often selected,but all treatment is less effective. In this paper,we discussed the concept and method of minimally invasive treatment dealing with patients with caudate hepatocellular carcinoma.
Reference | Related Articles | Metrics
Antimicrobial therapy in adult patients with bacterial liver abscess
Yu Shenglei,Weng Xinhua
JOURNAL OF PRACTICAL HEPATOLOGY    2015, 18 (4): 337-339.   DOI: 10.3969/j.issn.1672-5069.2015.04.001
Abstract292)      PDF(pc) (662KB)(2507)      
Reference | Related Articles | Metrics
The guideline of prevention and treatment for chronic hepatitis B(2015 version)
Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Infectious Diseases,Chinese Medical Association.
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (3): 389-400.   DOI: 10.3760/cma.j.issn.1007-3418.2015.12.034
Abstract369)      PDF(pc) (926KB)(2477)      
Related Articles | Metrics
Diagnosis and management of liver fibrosis
Guo Yuecheng, Lu Lungen
Journal of Practical Hepatology    2022, 25 (3): 305-308.   DOI: 10.3969/j.issn.1672-5069.2022.03.001
Abstract567)      PDF(pc) (826KB)(2437)      
Reference | Related Articles | Metrics
Advances in prevention and treatment of hepatic encephalopathy
Zhang Xuqing.
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (2): 121-124.   DOI: 10.3969/j.issn.1672-5069.2014.02.003
Abstract238)      PDF(pc) (569KB)(2378)      
Reference | Related Articles | Metrics
Diagnosis, severity assessment of hepatic fibrosis
Hu Ye, Zhang Guo.
JOURNAL OF PRACTICAL HEPATOLOGY    2017, 20 (1): 13-16.   DOI: 10.3969/j.issn.1672-5069.2017.01.005
Abstract315)      PDF(pc) (465KB)(2266)      
Reference | Related Articles | Metrics
Clinical detection of serum CEA,AFP,CA199 and Ferritin in diagnosis of patients with primary liver cancer
Dong Xinmin, Zhang Jian, Jin Yu.
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (3): 295-297.   DOI: 10.3969/j.issn.1672-5069.2014.03.019
Abstract426)      PDF(pc) (326KB)(2152)      
Reference | Related Articles | Metrics
What we should know about Gilbert syndrome
Deng Yuting , Wei Minhua, Zhou Junying
Journal of Practical Hepatology    2021, 24 (2): 156-159.   DOI: 10.3969/j.issn.1672-5069.2021.02.002
Abstract365)      PDF(pc) (863KB)(2107)      
Reference | Related Articles | Metrics
Nutritional assessment and support treatment of patients with liver cirrhosis
Cao Haixia, Fan Jiangao
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (5): 459-462.   DOI: 10.3969/j.issn.1672-5069.2014.05.004
Abstract251)      PDF(pc) (459KB)(2068)      
Reference | Related Articles | Metrics
Brief introduction of an international expert consensus statement: a new definition of metabolic associated fatty liver disease
Xue Rui, Fan Jiangao
Journal of Practical Hepatology    2020, 23 (3): 0-S58.   DOI: 10.3969/j.issn.1672-5069.2020.03.039
Abstract457)      PDF(pc) (597KB)(2016)      
Reference | Related Articles | Metrics
Liver failure related bacterial infection and antimicrobial treatment
Wang Yingjie
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (2): 117-120.   DOI: 10.3969/j.issn.1672-5069.2014.02.002
Abstract223)      PDF(pc) (586KB)(1963)      
Reference | Related Articles | Metrics
Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease(Version 2024)
Chinese Society of Hepatology, Chinese Medical Association
Journal of Practical Hepatology    2024, 27 (4): 494-510.  
Abstract1977)      PDF(pc) (3936KB)(1946)      
The Chinese Society of Hepatology of the Chinese Medical Association invited relevantexperts to revise and update the Guideline of Prevention and Treatment of Nonalcoholic Fatty Liver Disease(2018Version) and renamed it as (Version 2024) Guideline for the Prevention and Treatment of MetabolicDysfunction-associated (non-alcoholic) Fatty Liver Disease. Herein, the guiding recommendations on clinicalissues such as screening and monitoring, diagnosis and evaluation, treatment and follow-up of metabolicdysfunction-associated fatty liver disease are put forward.
Reference | Related Articles | Metrics
Comparative study of contrast-enhanced CT and contrast-enhanced ultrasonography in the diagnosis of patients with focal liver lesions
Zhang Hongchun,Geng Zhe.
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (6): 696-699.   DOI: 10.3969/j.issn.1672-5069.2016.06.014
Abstract313)      PDF(pc) (670KB)(1872)      
Objective To compare the value of contrast-enhanced CT and contrast-enhanced ultrasonography in the diagnosis of patients with focal liver lesions. Methods 81 patients with focal liver lesions were recruited in our hospital between March 2012 and May 2015. All the patients underwent contrast-enhanced CT check-up and contrast-enhanced ultrasonography. The imaging characteristics and the imaging parameters of ultrasonic contrast of benign and malignant liver lesions were recorded. Then,a comparison of the diagnostic efficacy of the two Methods was conducted. Results This study included 41 patients with hepatocellular carcinoma(HCC) and 40 with benign liver lesions. The quantitative analysis of the Results of contrast-enhanced ultrasonography revealed that time to peak,rise time and mean transit time in patients with malignant liver lesions were significantly shorter than those in patients with benign lesions [(33.2±5.8) s vs. (48.6±13.2) s,(24.1±4.9) s vs. (38.7±11.5) s,(108.5±21.3) s vs. (156.7±35.6) s,respectively,P<0.05 for all],while the perfusion index in patients with malignant liver lesions was significantly higher than that in patients with benign lesions[(145.3±39.2) vs.(83.6±17.9),P<0.05];The sensitivity,specificity,and accuracy of the contrast-enhanced ultrasonography were 97.1%, 92.3% and 96.3%,while those of contrast-enhanced CT were 80.3%(P<0.05),91.2%(P>0.05)and 85.2%(P<0.05). Conclusion Contrast-enhanced ultrasonography could provide abundant imaging information of hepatic lesions in terms of morphology and data measurement,with high sensitivity and diagnostic accuracy in diagnosis of patients with liver lesions.
Reference | Related Articles | Metrics
Therapeutic insights of traditional Chinese medicine in liver fibrosis
Zhao Zhimin, Liu Chenghai
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (1): 12-15.   DOI: 10.3969/j.issn.1672-5069.2016.01.004
Abstract309)      PDF(pc) (476KB)(1859)      
Reference | Related Articles | Metrics
Diagnosis and treatment of hepatocellular jaundice
Yang Min, Lu Mingqin
JOURNAL OF PRACTICAL HEPATOLOGY    2018, 21 (2): 160-162.   DOI: 10.3969/j.issn.1672-5069.2018.02.003
Abstract748)      PDF(pc) (439KB)(1759)      
Reference | Related Articles | Metrics
Chronic liver disease and thrombocytopenia:Changes in clinical management concept
Tang Chengwei
JOURNAL OF PRACTICAL HEPATOLOGY    2019, 22 (4): 457-458.   DOI: 10.3969/j.issn.1672-5069.2019.04.001
Abstract218)      PDF(pc) (351KB)(1746)      
Reference | Related Articles | Metrics
Endoplasmic reticulum stress-induced unfolded protein response in medicine
Guo Yuanyuan, Ren Feng, Duan Zhongping, et al
JOURNAL OF PRACTICAL HEPATOLOGY    2015, 18 (1): 92-96.   DOI: 10.3969/j.issn.1672-5069.2015.01.027
Abstract310)      PDF(pc) (763KB)(1737)      
Endoplasmic reticulum(ER) homeostasis is perturbed by various pathological conditions,and a given new synthesized unfolded proteins might accumulate in the ER and result in endoplasmic reticulum stress(ERS). ERS is related to the pathogenesis of the various liver diseases,and some scholars believe that the intervention of ERS will provide new choices for prevention and treatment of liver diseases. This paper will review the unfolded protein response due to ERS,which might be the target for medical intervention for liver diseases.
Reference | Related Articles | Metrics
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (5): 557-560.   DOI: 10.3969/j.issn.1672-5069.2014.05.032
Abstract261)      PDF(pc) (718KB)(1733)      
Reference | Related Articles | Metrics
Brief introduction of European Clinical Practice Guidelines for the management of patients with non-alcoholic fatty liver diseases
Xing Fengzhi, Fan Jiangao
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (4): 511-511.   DOI: 10.3969/j.issn.1672-5069.2016.04.038
Abstract269)      PDF(pc) (269KB)(1725)      
Reference | Related Articles | Metrics
Serum markers in patients with non-alcoholic fatty liver disease
Huang Die, Tian Haoyu, Li Yiling
Journal of Practical Hepatology    2022, 25 (2): 297-300.   DOI: 10.3969/j.issn.1672-5069.2022.02.037
Abstract413)      PDF(pc) (846KB)(1704)      
Objective Non-alcoholic fatty liver diseases (NAFLD) is the most prevalent chronic liver disease worldwide at present, and the main mechanisms involved in the pathogenesis include insulin resistance, oxidative stress and so on. Different serum markers are closely related to the pathogenesis of NAFLD, but there is no clear conclusion yet. This article reviewed the important role of different serum markers in patients with NAFLD.
Reference | Related Articles | Metrics
Oral tauroursodeoxycholic acid administration after minimal invasive gall stone surgery in the treatment of patients with cholecystolithiasis
He Fang, Zhang Guangquan
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (3): 317-319.   DOI: 10.3969/j.issn.1672-5069.2014.03.030
Abstract243)      PDF(pc) (318KB)(1687)      
Reference | Related Articles | Metrics
Comparison of gelatin sponge particle and embosphere microsphere embolization in treatment of patients with spontaneous rupture of hepatocellular carcinoma
Yang Jun, Cui Hongli, Yan Qixian, et al.
JOURNAL OF PRACTICAL HEPATOLOGY    2015, 18 (6): 651-654.   DOI: 10.3969/j.issn.1672-5069.2015.06.021
Abstract396)      PDF(pc) (684KB)(1684)      
Objective To explore the efficacy of the gelatin sponge particle and embosphere microsphere embolization for the treatment of patients with hepatocellular carcinoma and tumor rupture. Methods 49 patients with rupture of hepatocellular carcinoma underwent transcatheter arterial embolization by gelatin sponge particle (n=23) or embosphere microsphere(n=26) embolization in recent 5 years,and instant hemostatic and rehaemorrhagia rates were compared. Results There was no difference between gelatin sponge particle and embosphere microsphere embolization on the effects of instant hemostatic(both were 100%);Seven days after intervention,the rehaemorrhagia rate in gelatin sponge particles was 13.0%(3/23),one patient was transferred to surgery,one patient was re-intervened and one patient dead because of haemorrhagic shock,respectively;The rehaemorrhagia rate in embosphere microspheres group was 3.8%(1/26,P<0.01),and the patient received re-intervention and the bleeding was stopped successfully. Conclusion The instant hemostatic effect is the same between the gelatin sponge particle and embosphere microspheres embolization in patients with rupture of hepatocellular carcinoma,however,the embosphere group has much less chance to rebleeding within 7 days.
Reference | Related Articles | Metrics
Improvement of embolic materials in vascular inteventional therapy of patients with primary liver cancer
Liu Hui, Chen dongfeng
JOURNAL OF PRACTICAL HEPATOLOGY    2015, 18 (3): 333-336.   DOI: 10.3969/j.issn.1672-5069.2015.02.034
Abstract405)      PDF(pc) (702KB)(1645)      
Vascular inteventional therapy has played an important role in patients with unresectable primary liver cancer(PLC),while the effect of vascular interventional therapy is closely related to the choice of embolic materials. We reviewed the characteristics and the clinical application of common embolic materials used in vascular inteventional therapy.
Reference | Related Articles | Metrics
Diagnosis and differential diagnosis of patients with hepatic vascular diseases
Bai Tingting, Liu Yuyi, Chen Dongfeng
Journal of Practical Hepatology    2023, 26 (2): 153-155.   DOI: 10.3969/j.issn.1672-5069.2023.02.001
Abstract237)      PDF(pc) (808KB)(1643)      
Reference | Related Articles | Metrics
Pharmacokinetics and adverse reactions of copper ion chelating agents
Tian Chi, Huang Xiameng, Wang Ting
JOURNAL OF PRACTICAL HEPATOLOGY    2015, 18 (2): 221-224.   DOI: 10.3969/j.issn.1672-5069.2015.02.033
Abstract575)      PDF(pc) (739KB)(1582)      
Copper chelators,such as penicillamine,trientine and dimercaptosuccinic acid,ets,has been commonly used in treatment of patients with Wilson's disease(WD). We summarized some different types of adverse reactions often occurredin clinical practice and introduced some pharmacokinetic data,which might be useful for clinicians.
Reference | Related Articles | Metrics
Role of Nrf2 in the regulation of hepatocyte apoptosis
Cui Dan,Yang Baoshan
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (3): 365-368.   DOI: 10.3969/j.issn.1672-5069.2016.03.031
Abstract314)      PDF(pc) (731KB)(1576)      
Hepatocyte apoptosis can be divided into physiological and pathologicalapoptosis. Both of them are relevant to the progression of liver disease. Reactive oxygen species(ROS) play an important role in the induction of hepatocyteapoptosis. Recently, some reports show thatnuclear factor E2-related fator 2(Nrf-2) represents one of the mostimportant cellular defense mechanisms against oxidative stress,inflammatory and tumorigenesis. Here,we reviewed the mechanisms of signal transduction involved in Nrf-2 related pathway and its possible roles in the process of hepatic apoptosis under oxidative stress.
Reference | Related Articles | Metrics
Focal solid liver lesions: Imaging diagnosis
Wang Wentao, Rao Shengxiang
JOURNAL OF PRACTICAL HEPATOLOGY    2018, 21 (4): 493-495.   DOI: 10.3969/j.issn.1672-5069.2018.04.002
Abstract268)      PDF(pc) (392KB)(1575)      
Reference | Related Articles | Metrics
A randomized controlled trial of ursodeoxycholic acid in treating patients with primary biliary cirrhosis
Guo Rui, Tan Jin.
JOURNAL OF PRACTICAL HEPATOLOGY    2017, 20 (1): 109-110.   DOI: 10.3969/j.issn.1672-5069.2017.01.030
Abstract428)      PDF(pc) (661KB)(1574)      
Reference | Related Articles | Metrics
Maintenance of internal environment homeostasis in patients with liver failure
Nie Qinghe,Zhu Ting.
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (2): 125-128.   DOI: 10.3969/j.issn.1672-5069.2014.02.004
Abstract142)      PDF(pc) (606KB)(1572)      
Reference | Related Articles | Metrics
Progress in diagnosis and treatment of patients with portopulmonary hypertension
Cai Junjun,Han Tao.
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (2): 214-217.   DOI: 10.3969/j.issn.1672-5069.2014.02.029
Abstract231)      PDF(pc) (506KB)(1558)      
Portopulmonary hypertension (PPHTN) is defined as the development of pulmonary arterial hypertension associated with increased pulmonary vascular resistance complicating portal hypertension, with or without advanced liver disease. The presence of PPHTN markedly increases mortality. No effective medical therapies are currently available and liver transplantation is the only accepted treatment at the time. This review stresses on the epidemiology, pathophysiology, clinical presentation, diagnosis, treatment and the prognosis of PPHTN.
Reference | Related Articles | Metrics
Signaling pathways in hepatic fibrosis
Li Xin, Zhu Ying
JOURNAL OF PRACTICAL HEPATOLOGY    2015, 18 (1): 101-104.   DOI: 10.3969/j.issn.1672-5069.2015.01.029
Abstract457)      PDF(pc) (734KB)(1538)      
Hepatic fibrosis (HF) is a pathological process in a variety of chronic liver diseases, which may eventually progressed to cirrhosis or even liver cancer. Therefore,how to delay,cease or reverse HF is particularly important. HF is a complicated process that is involved by various cytokines and cell signaling pathways. Elucidation of these signaling pathways might provide some approaches to intervene the development of HF.
Reference | Related Articles | Metrics
Evaluation of reliability and validity of self-rating anxiety scale and self-rating depression scale in patients with liver cirrhosis
Tian Yindi, Wang Yikai, Li Jing, et al.
JOURNAL OF PRACTICAL HEPATOLOGY    2019, 22 (1): 105-108.   DOI: 10.3969/j.issn.1672-5069.2019.01.028
Abstract851)      PDF(pc) (932KB)(1538)      
Objective This study was designed to evaluate of reliability and validity of self-rating anxiety scale(SAS) and self-rating depression scale(SDS) in patients with liver cirrhosis. Methods A total of 138 patients with liver cirrhosis were enrolled in this study. The reliability and validity of the two scales was evaluated by Cronbach’s α co-efficient,intraclass correlation co-efficient (ICC),Kaiser-Meyer-Olkin (KMO) score and Bartlett’s test of sphericity(BTS). Results The prevalence of anxiety and depression in this series were 38.2% and 63.1%,respectively;SAS scale’ Cronbach's α coefficient was 0.777 and SDS scale’ was 0.782, indicating better homogeneity reliability; Twenty items of SAS and SDS scales were analyzed by exploratory factors to construct validity and four main factors were extracted from the SAS scale that showed the variances ratio were 15.4%,14.9%,10.6% and 10.2%,respectively,and four factors accounted for 51.1% of the total variance of accumulated explanation;Five main factors were extracted from SDS scales that showed the variance ratio were 14.0%,12.6%,11.9%,10.3% and 8.4%,respectively,with 57.4% of the total variance;The re-measurement analysis of SAS and SDS scale’s items found that the two measurements were highly correlated with each other (P<0.001). Conclusion SAS and SDS scales have a better reliability and validity in the investigation of psychological and mental impairment in patients with liver cirrhosis.
Reference | Related Articles | Metrics
Practice of chronic disease management: What we should do in patients with non-alcoholic fatty liver diseases
He Fangping
Journal of Practical Hepatology    2023, 26 (4): 460-462.   DOI: 10.3969/j.issn.1672-5069.2023.04.002
Abstract189)      PDF(pc) (806KB)(1536)      
Reference | Related Articles | Metrics
Anti-hepatic fibrosis therapy
Hu Ye, Zhang Guo
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (1): 8-11.   DOI: 10.3969/j.issn.1672-5069.2016.01.003
Abstract263)      PDF(pc) (437KB)(1517)      
Reference | Related Articles | Metrics
Nonalcoholic fatty liver disease and liver cirrhosis
Ma Zhenzeng, Lu Lungen
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (2): 135-138.   DOI: 10.3969/j.issn.1672-5069.2016.02.003
Abstract217)      PDF(pc) (578KB)(1517)      
Reference | Related Articles | Metrics
Progress in the pathogenesis of liver fibrosis
Chen Xiaoyu, Yang Changqing
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (1): 121-124.   DOI: 10.3969/j.issn.1672-5069.2016.01.035
Abstract448)      PDF(pc) (718KB)(1516)      
Liver fibrosis is a pathological process characterized by intrahepatic diffuse excess deposition of extracellular matrix (ECM),which is also a common response occurred in the progression of varied chronic liver disease to cirrhosis. As ECM is mainly secreted by hepatic stellate cells(HSC) and its activation process is the central part of liver fibrosis development. In this review,we will summarize the mechanism of HSC activation in combination with the roles of hepatocytes,other non-parenchymal cells and various profibrogenic cytokines. This paper will also describe the significance of intestinal flora alteration and aberrant expression of microRNAs in the development of liver fibrosis.
Reference | Related Articles | Metrics
A new model for prevention and treatment of MAFLD to promote whole process stratification management
Zhang Wei, Shi Junping
Journal of Practical Hepatology    2020, 23 (5): 609-611.   DOI: 10.3969/j.issn.1672-5069.2020.05.001
Abstract307)      PDF(pc) (884KB)(1497)      
Reference | Related Articles | Metrics
Nutritional support in patients with alcoholic liver disease
Wang Yingchun, Kong Weizong
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (5): 456-458.   DOI: 10.3969/j.issn.1672-5069.2014.05.003
Abstract211)      PDF(pc) (429KB)(1474)      
Reference | Related Articles | Metrics